• No results found

Advanced Prostate Cancer

Endothelin inhibitors for advanced prostate cancer

Endothelin inhibitors for advanced prostate cancer

... Prostate cancer is the second most frequently diagnosed cancer, and the sixth most common fatal cancer, in men ...2010). Prostate cancer is rarely diagnosed before the age of 50, ...

11

Acupuncture for the Treatment of Hot Flashes in Men with Advanced Prostate Cancer

Acupuncture for the Treatment of Hot Flashes in Men with Advanced Prostate Cancer

... Our study clearly demonstrates that acupuncture is safe and effective in reducing hot flashes in men with advanced prostate cancer undergoing androgen depriva- tion therapy following 14 weeks of ...

5

Spirituality in men with advanced prostate cancer

Spirituality in men with advanced prostate cancer

... with advanced prostate cancer, you’ve got to go out and find it all yourself, and that’s no disrespect to the medical specialists and the ...about prostate cancer support ...

307

Future of bisphosphonates and denosumab for men with advanced prostate cancer

Future of bisphosphonates and denosumab for men with advanced prostate cancer

... Abstract: Prostate cancer is the most common cancer occurring in American men of all ...of cancer death among men in the ...with advanced prostate cancer, with ...

8

The role of radiotherapy in localised and locally advanced prostate cancer

The role of radiotherapy in localised and locally advanced prostate cancer

... non-metastatic prostate cancer, the individualized recommendation of radiotherapy has to be the fruit of a multidisciplinary approach in the context of a Tumor Board, to be explained carefully to the ...

9

Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.

Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.

... In advanced prostate cancer (PC), there is increasing investigation of circulating biomarkers, including quantitation and characterization of circulating tumour cells and cell-free nucleic acids, for ...

9

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.

... Gallen Advanced Prostate Cancer Consensus Conference (APCCC) Expert Panel identi fi ed and reviewed the available evidence for the ten most important areas of controversy in advanced ...

16

A Canadian consensus forum on the management of patients with advanced prostate cancer

A Canadian consensus forum on the management of patients with advanced prostate cancer

... of advanced prostate cancer and will be of value to Canadian prostate cancer ...Canadian prostate cancer physicians have synthesized the best available data and then ...

30

A review of tasquinimod in the treatment of advanced prostate cancer

A review of tasquinimod in the treatment of advanced prostate cancer

... These preclinical data demonstrated the potential utility of tasquinimod when coupled within conventional chemo- therapy and hormonal based approaches to treat advanced prostate cancer. In addition, ...

8

Sipuleucel-T: immunotherapy for advanced prostate cancer

Sipuleucel-T: immunotherapy for advanced prostate cancer

... Abstract: Prostate cancer continues to be one of the most serious afflictions of men of advanced age, remaining the most commonly diagnosed and second leading cause of cancer-related deaths in ...

12

Understanding locally advanced and advanced prostate cancer

Understanding locally advanced and advanced prostate cancer

... advanced prostate cancer may affect how you feel within yourself as well as how you might relate to others around ...the prostate cancer is not responding well enough to the current ...

45

Rationale for Modernising Imaging in Advanced Prostate Cancer.

Rationale for Modernising Imaging in Advanced Prostate Cancer.

... Gallen Advanced Prostate Cancer Consensus Conference (APCCC), most oncologic experts accepted that novel imaging techniques (positron emission tomography [PET]/computed tomography [CT] with different ...

17

The measurement of response shift in patients with advanced prostate cancer and their partners

The measurement of response shift in patients with advanced prostate cancer and their partners

... with advanced prostate cancer and/or their ...with advanced prostate can- cer [20], it was not known how such patients would assess other factors relating to their diagnosis, or how ...

8

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence

The association between metabolic syndrome and the risk of prostate cancer, high-grade prostate cancer, advanced prostate cancer, prostate cancer-specific mortality and biochemical recurrence

... and prostate cancer risk or prostate cancer parameters is that we did not perform a meta-regression to attempt to explain the heterogeneity of the study because of the varying adjustments in ...

11

Critical appraisal of cabazitaxel in the management of advanced prostate cancer

Critical appraisal of cabazitaxel in the management of advanced prostate cancer

... be a single-arm study evaluating cabazitaxel alone in patients with taxane-resistant metastatic breast cancer. In the setting of patients who had received adjuvant or neoadjuvant taxane therapy, resistance was ...

8

CD117 cells in the circulation are predictive of advanced prostate cancer

CD117 cells in the circulation are predictive of advanced prostate cancer

... certain cancer patients experience relapse after treatment for clinically localized disease is ...if prostate cancer metastasis is driven by this small population of CSCs, it might explain the ...

9

Galeterone for the treatment of advanced prostate cancer:  the evidence to date

Galeterone for the treatment of advanced prostate cancer: the evidence to date

... develop confirmed radiographic progression of their disease (according to Prostate Cancer Working Group 2 criteria), or if they develop unmanageable toxicity. The primary endpoint of ARMOR3-SV is rPFS, with ...

9

Genomic correlates of clinical outcome in advanced prostate cancer.

Genomic correlates of clinical outcome in advanced prostate cancer.

... metastatic prostate cancer has become apparent through several comprehensive profiling efforts, but little is known about the impact of this heterogeneity on clinical ...castration-resistant prostate ...

9

Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer

Enzalutamide as a second generation antiandrogen for treatment of advanced prostate cancer

... of cancer therapy, time to biochemical reoccurrence defined by $25% increase, and $2 ng/mL absolute increase in PSA, percentage of patients with pain palliation, percentage of patients with PSA response, ...

7

Advanced Prostate Cancer: A Case Report

Advanced Prostate Cancer: A Case Report

... DOI: 10.4236/oju.2019.91002 16 Open Journal of Urology that it is a prostatic extension of a primary tumor from the colon. Bleeding of the upper gastrointestinal tract objectified during recto-sigmoidoscopy, would be an ...

8

Show all 10000 documents...

Related subjects